The group B streptococcus (GBS) is an important human pathogen with the ability to cause invasive disease. To do so, the bacteria must invade host cells. It has been well documented that GBS are able to invade a variety of nonphagocytic host cell types, and this process is thought to involve a number of pathogen-host cell interactions. While some of the molecular aspects of the GBS-host cell invasion process have been characterized, many events still remain unclear. The objective of this investigation was to evaluate the role of the Rho-family GTPases Rac, Rho, and Cdc42 in GBS invasion into epithelial cells. The epithelial cell invasion process was modeled using HeLa 229 cell culture. Treatment of HeLa cells with 10 mM compactin, a pan-GTPase inhibitor, abolished GBS internalization, suggesting that GTPases are involved in the GBS invasion process. The addition of Toxin B or exoenzyme C3 to HeLa cells before GBS infection reduced invasion by 50%, further suggesting that the Rho-family GTPases are involved in GBS entry. Examining invasion of GBS into HeLa cells with altered genetic backgrounds was used to confirm these findings; GBS invasion into HeLa cells transiently transfected with dominant negative Rac1, Cdc42, or RhoA reduced invasion by 75%, 51%, and 42%, respectively. Results of this study suggest that the Rho-family GTPases are required for efficient invasion of HeLa cells by GBS.
Introduction
For a bacterial pathogen, the ability to invade nonphagocytic host cells presents a number of advantages, such as the ability to overcome unfavorable host conditions, become inaccessible to the host's immune system or gain access to privileged sites within the host. To augment the invasion process, numerous bacterial pathogens have evolved mechanisms to interact with host cells by usurping or parasitizing existing machinery and signaling cascades.
The Rho-family GTPases are ubiquitous small GTPases that function as 'molecular switches' within eukaryotic cells that interact with a diverse array of downstream effector molecules, and control signal transduction pathways by linking membrane events to cytoskeletal modulation. Manipulation of host cell signaling pathways by an invasive pathogen can be a key event in bacterial survival and dissemination and, therefore, Rho GTPases are major targets for virulence factors of several bacterial pathogens. C3 exoenzyme was the first bacterial protein demonstrated to interfere with functionality of Rho GTPases (Aktories et al., 1987) , and since then, many other bacterial factors have been identified that interact with this family of molecules, either directly or indirectly, and as activators or inhibitors.
The group B streptococcus (GBS) is an important human pathogen with the ability to cause invasive disease. In the Western world, GBS are the leading cause of meningitis in infants o 1 month of age (Schuchat et al., 1997) . This is believed to be a consequence of passage of the organism to the infant during delivery by a colonized mother (Schuchat, 1998; Tyrrell et al., 2000) . In addition to meningitis, GBS infections in infants can include pneumonia, sepsis, and soft tissue infections. GBS serotypes Ia, Ib, and III are most strongly associated with neonatal infections. Invasive GBS infections are not reserved for infancy but also occur in adulthood, especially in the elderly or in those individuals with an underlying chronic disease, such as diabetes mellitus (Schuchat et al., 1990 (Schuchat et al., , 1998 Farley et al., 1993; Tyrrell et al., 2000) . Serotype V is a major cause of GBS infection in adulthood, especially in North America. Disease manifestations of invasive GBS infection in adults include meningitis, pneumonia, sepsis, and infections of bone and soft tissue.
To cause infection, GBS must be able to subvert a variety of host cell types, such as host epithelial cells, which are a major component of innate immunity and, in many cases, pose as the host's first line of defense against bacterial assault. There have been numerous investigations focused on the invasion of bacterial pathogens into host cells in recent years. While it has been well documented that GBS are able to invade a variety of cell types, including epithelial and endothelial cells (Gibson et al., 1993; Valentin-Weigand et al., 1997; Lalonde et al., 2000; Tyrrell et al., 2002; Shin & Kim, 2006) , the specific molecular mechanisms involved in this process remain relatively uncharacterized. What has been established, however, is that host cell actin microfilaments are recruited during the process of GBS attachment and subsequent invasion. This was demonstrated by showing that cytochalasin D, a potent inhibitor of actin polymerization, inhibits GBS invasion into epithelial cells (Gibson et al., 1993; Valentin-Weigand et al., 1997; Tyrrell et al., 2002) , and that actin is recruited to the site of GBS attachment (Tyrrell et al., 2002) .
The Rho-family GTPases are obvious candidates for participation in GBS-induced actin manipulation, as it is well established that activation of these moieties is involved in actin nucleation and polymerization, leading to the alteration or formation of cytoskeletal structures within the host, such as actin bundling. Consequences of these events include formation of membrane protrusions, phagocytosis, vesicle trafficking, and cytokinesis. The objective of this investigation was to evaluate the role of the Rho-family GTPases Rac, Rho, and Cdc42 in GBS invasion into epithelial cells; chemical modulators of these GTPases as well as dominant negative forms of Rac, Rho, and Cdc42 were used in conjunction with an antibiotic protection invasion assay to address this objective.
Materials and methods

Bacterial strains, cell lines, and growth conditions
The serotype V GBS strain NCS13 was isolated from the soft tissue wound of an elderly patient, and has been previously described (Tyrrell et al., 2002) . The Salmonella enterica serovar Typhimurium (S. typhimurium) control strain NCTC 10241 was obtained from the National Culture Collection, PHLS Colindale, London, UK. These organisms were cultured at 35 1C on sheep blood agar plates (BAPs) (Dalynn Biologicals, Calgary, AB, Canada) or in ToddHewitt broth (THB) (Difco Laboratories, Detroit, MI).
The human epithelial cell line HeLa 229 (ATCC CCL-2.1) was obtained from the American Type Culture Collection (ATCC; Manassas, VA) and was grown in Opti-MEM I reduced serum medium supplemented with 4% fetal bovine serum (FBS) (Gibco BRL, Burlington, ON, Canada).
Chemical inhibitors
Compactin (mevastatin), Y-27632 dihydrochloride, L-a-lysophosphatidic acid (LPA), Clostridium difficile Toxin B (ToxB), and ADP-ribosyltransferase C3 were purchased from the Sigma Chemical Co. (St Louis, MO). HeLa cells were treated with compactin for 18 h and ToxB for 3 h before infection with bacteria. For treatment with exoenzyme C3, the cells were incubated for 18 h in the presence of 1 mg mL
À1
Lipofectamine
TM 2000 (Invitrogen Life Technologies, Burlington, ON, Canada), a modification of the previously described Lipofectamine procedure (Borbiev et al., 2000) . HeLa cells were incubated with the other inhibitors for 1 h before bacterial infection of the cells. The inhibitors were present during the invasion assay until the first wash when the fresh media with antibiotics was added.
Invasion (antibiotic protection) assay
Invasion of bacteria into epithelial cell cultures was quantified using a standard antibiotic protection invasion assay with minor modifications (Rubens et al., 1992; Tyrrell et al., 2002) ; this assay has been used extensively to investigate the streptococcal invasion process (Valentin-Weigand et al., 1997; Ozeri et al., 2001; Purushothaman et al., 2003; Shin & Kim, 2006) . Briefly, HeLa cell monolayers were grown to confluence in 24-well plates, and then treated with chemical inhibitors. GBS or S. typhimurium were grown in THB overnight. A 0.5 McFarland standard of organism was made in THB and then diluted 1 in 100 in THB. For GBS, 100 mL of this suspension (c. 1.5 Â 10 5 bacteria) and for S. typhimurium 25 mL of this suspension (c. 4 Â 10 4 bacteria) was applied to the monolayer. The difference in inoculum is reflective of the fact that S. typhimurium invades epithelial cells with higher efficiency than GBS. Following inoculation, the plates were centrifuged at 100 g for 5 min at room temperature. After incubating at 35 1C for 2 h to allow bacterial internalization, the monolayer was washed three times with phosphate-buffered saline (PBS) to remove unbound bacteria. Any bacteria that had bound but not internalized were killed by incubation for 2 h with fresh media containing 5 mg of penicillin mL À1 and 100 mg of gentamicin mL À1 . After the 2 h incubation, an aliquot of media was applied to a BAP to ensure that the antibiotic treatment was effective and all extracellular bacteria were successfully killed. The monolayers were washed with PBS, trypsinized, and then lysed with 0.1% Triton X-100. The lysates were spread onto BAPs and incubated overnight at 35 1C. The number of colonies on each plate was counted to determine the number of CFU that had invaded the cell monolayer. For the 'zero' concentration for each inhibitor, the solvent for that inhibitor (e.g. dimethyl sulfoxide) was added to the cells at a concentration equal to the solvent concentration present during the inhibitor treatment (control cells). The integrity of the epithelial cell monolayer following inhibitor treatment was evaluated with microscopy. The cells were examined at the end of each incubation period during the assay to observe any morphological changes induced by the inhibitors. Portions of the HeLa cell culture supernatants were plated on to BAPs following the 2 h infection time with GBS and S. typhimurium to ensure that the inhibitor treatments were not resulting in reduced bacterial viability.
Transient transfection of HeLa cells
Plasmids expressing dominant negative Rac (pcDNA3-EGFP-Rac1-T17N), Rho (pcDNA-EGFP-RhoA-T19N), and Cdc42 (pcDNA-EGFP-Cdc42-T17N) were generously provided by Dr Garry Bokoch (The Scripps Research Institute, La Jolla, CA) (Zhang et al., 1995; Ben-Ami et al., 1998; Subauste et al., 2000) . For transient transfection assays, HeLa cells were grown to c. 80-90% confluence in 24-well culture dishes. The culture media was replaced with serumfree Opti-MEM I, and 1 mg of plasmid DNA and 2 mg of Lipofectamine TM 2000 Transfection Reagent (Invitrogen Life Technologies, Burlington, ON, Canada) were added to the cells according to the manufacturer's instructions. After 5 h incubation, the cell culture media was replaced with fresh Opti-MEM I with 4% FBS and the cells were incubated overnight at 37 1C.
A subset of transfected cells were grown on glass coverslips in the 24-well plates. Hoechst Dye (Sigma Chemical Co., St Louis, MO) was used to stain cell nuclei before visualization of the coverslips by fluorescence microscopy (Olympus Microscopes, Carsen Group Inc., Markham, ON, Canada) to evaluate transfection efficiency. The proportion of green fluorescent protein (GFP) expressing cells was visually compared with the total cell population.
Statistical analysis
For the invasion assays, relative percent internalization was calculated as follows: [(Number of CFU invaded into cells with inhibitor treatment/number of CFU invaded into control cells) Â 100%]. GRAPHPAD INSTAT 3 software was used for statistical analysis of the data; Dunnet's multiple comparisons test was used to compare the invasion into inhibitor-treated or transfected cells to invasion into untreated control cells. A P value o 0.05 was considered statistically significant and is designated by the character Ã on the graphical representations. Each assay was performed at least three times and the graphical representations are illustrative of the mean of one representative experiment in which each assay condition was performed in triplicate. Error bars represent standard error of the mean (SEM).
Results
The pan-GTPase inhibitor compactin blocks GBS uptake into epithelial cells
Compactin is a pan-GTPase inhibitor that prevents posttranslational modifications essential for GTPase function, such as Rho geranylgeranylation (Seabra, 1998) . Compactin was used to screen for potential involvement of GTPases in the GBS internalization process. HeLa cell monolayers were treated with compactin for 18 h before GBS infection. Compactin had a potent inhibitory effect on GBS invasion, with over 90% reduction in internalization seen at a concentration of 10 mM (Fig. 1) .
Clostridium difficile ToxB inhibits GBS internalization
The Rho family GTPases regulate the organization and assembly of the actin cytoskeleton in all eukaryotic cells (Hall, 1998; Burridge & Wennerberg, 2004) . The strong inhibitory effect of compactin treatment on GBS invasion further suggested Rho-family GTPases could be involved in this process. To investigate this possibility, HeLa cells were treated with ToxB from C. difficile. ToxB inactivates Rac, Rho, and Cdc42 by monoglucosylating these moieties in the GTPase binding pocket, thereby rendering them inactive (Aktories, 1997) . ToxB inhibited GBS internalization in a dose-dependant manner with c. 50% reduction in invasion occurring at 100 ng mL À1 (Fig. 2) . This is similar to what is observed for S. typhimurium, a pathogen whose invasion has been previously reported to be inhibited by ToxB (Criss & Casanova, 2003) .
Chemical inhibition of Rho results in reduced GBS invasion
Clostridium botulinum C3 exoenzyme is an ADP ribosyltransferase that inactivates Rho, resulting in redistribution of the actin cytoskeleton due to interferences of Rho interaction with its effectors (such as Rho kinase). As a consequence, changes in cellular morphology, such as cell rounding, are observed (Aktories, 1997) . In contrast to many other bacterial toxins, C3 exoenzyme lacks a membrane binding and/or transfer component and thus cannot permeate the cell cytoplasm independently to reach its effectors. Hence, lipofectamine reagent needs to be used in concert with the C3 exoenzyme to permit toxin entry into the host cell (Borbiev et al., 2000) . HeLa cells were treated with lipofectamine, C3 exoenzyme, or both for 18 h before GBS infection. Treatment of the HeLa cells with C3 exoenzyme alone did not inhibit GBS invasion (Fig. 3a) . However, the C3 exoenzyme/lipofectamine combination treatment inhibited GBS invasion by 50% (Fig. 3a) , suggesting that Rho specifically is involved in GBS invasion.
Activation of Rho leads to increased GBS invasion
LPA is a growth factor that activates Rho, leading to the formation of stress fibres and focal adhesions (Tapon & Hall, 1997; Hall, 1998; Meerschaert et al., 1998) . Since inhibition experiments of this study suggested that Rho is involved in GBS invasion, it was investigated if the activation of Rho by LPA would have an effect on the GBS internalization process. At a concentration of 50 mM, LPA increased GBS invasion of HeLa cells by nearly 50% (Fig. 3b) . In contrast, S. typhimurium invasion was unaffected by the LPA treatment (Fig. 3b) .
Inactivation of Rac1, RhoA, and Cdc42 inhibits invasion of GBS into epithelial cells
To further investigate the individual role of Rho-family GTPases, dominant negative forms of these moieties were used. HeLa cells were transiently transfected with the dominant negative form of Rac1 (Rac1-T17N), RhoA (RhoA-T19N) or Cdc42 (Cdc42-T17N). Each of these constructs was fused with GFP to allow for microscopic evaluation of the transfection efficiency, which varied from c. 60% to 70%. S. typhimurium was assayed in parallel as a control. As expected, the internalization of S. typhimurium was reduced in the cells expressing the dominant negative form of Rac1 and Cdc42, but not RhoA (Fig. 4) (Chen et al., 1996; Lesser et al., 2000; Criss & Casanova, 2003) . In contrast, the internalization of GBS was reduced in each of the transfected cell types examined. Rac1-T17N resulted in 75% reduction in GBS invasion, Cdc42-T17N a 51% reduction, and RhoA-T19N a 42% reduction compared with control HeLa cells (Fig. 4) . These data confirm the results of the chemical inhibitor studies, and suggest that Rac, Rho, and Cdc42 are each involved in GBS invasion into host epithelial cells.
Inhibition of the Rho effector protein Rhokinase (ROCK) inhibits GBS internalization.
ROCK is a downstream Rho effector (Maekawa et al., 1999; Burridge & Wennerberg, 2004) , and has been implicated in Rho-mediated actin reorganization (Ohashi et al., 2000) . Y27632 dihydrochloride is a highly potent and specific inhibitor of ROCK. Invasion of HeLa cells by S. typhimurium, which invades independently of Rho (Criss & Casanova, 2003) , was not reduced by Y27632 treatment (Fig. 5) . Treatment of HeLa cells with Y27632 before GBS infection inhibited invasion in a dose-dependant manner, with 30 % inhibition at 5 mM and 65% inhibition at 20 mM (Fig. 5) .
Discussion
Although GBS colonize some individuals asymptomatically, they are also capable of causing devastating invasive disease. While it has been well established that GBS are able to invade epithelial cells, and that this contributes to the disease process, the specifics of GBS cellular invasion remain largely uncharacterized. Previous studies have demonstrated that actin manipulation is a critical event in GBS invasion into host cells (Gibson et al., 1993; Valentin-Weigand et al., 1997; Tyrrell et al., 2002) . The goal of this study was to examine the cellular processes leading up to and involved in host cell actin manipulation by this pathogen.
The Rho-family GTPases are a set of 'molecular switches' that have been studied extensively and are implicated in multiple facets of cytoskeletal regulation. The role of the Rho GTPases in bacterial pathogenesis has been the focus of numerous investigations. Although one or more members of this family of GTPases may participate in the bacterial invasion process, there is a great variation between different pathogens with regard to the kinetics of activation, protein binding partners, and signal transduction cascades involved. The results of this study illustrate that Rac, Rho, and Cdc42 are each involved in efficient invasion of HeLa cells by GBS.
It appears that the utilization of Rho GTPases by a bacterial pathogen to invade host cells can vary depending on the cell type. For example, in a study exploring RhoA and Rac1 in GBS invasion into human brain microvascular endothelial cells (HBMEC), Shin & Kim (2006) observed that GBS exhibit reduced internalization into HBMEC expressing dominant negative Rac1 and RhoA, but dominant negative expression of Cdc42 in HBMEC cells did not reduce GBS invasion as it did in HeLa cells. The finding that the ROCK inhibitor Y27632 reduced GBS internalization into HeLa cells points to ROCK as a downstream Rho effector utilized in the GBS invasion process of these cells. In contrast, Y27632 treatment before infection does not reduce GBS invasion into HBMEC cells (Shin & Kim, 2006) . This suggests that different downstream Rho effector proteins may be recruited or manipulated during endothelial and epithelial cell invasion. It is interesting to note that the effect of ToxB on GBS invasion is not as potent as the reported effect on group A streptococcal (GAS) internalization. With GAS, 5 ng mL À1 ToxB reduces GAS invasion into HeLa cells by over 90% (Ozeri et al., 2001 ) whereas 100 ng mL À1 was required to achieve a 50% reduction in invasion for GBS. The finding that RhoA-T19N inhibits GBS invasion is of particular interest, as this is in contrast with investigations by Ozeri et al. (2001) who observed that dominant negative expression of RhoA in MDCK cells resulted in a marked increase in GAS internalization. This finding could suggest a possible point of difference in host cell cytoskeleton exploitation and host cell signal transduction pathways utilized by these two organisms for invasion. Throughout the literature, involvement of RhoA in the invasion process seems to best relate to the 'zipper mechanism' of bacterial internalization, whereby engulfment of bacteria into the host cell does not require large membrane extensions. The invasion of Brucella abortus in to HeLa cells is an example of this; the invasion of this pathogen requires Rho (as well as Rac and Cdc42), but occurs with cytoskeletal rearrangements that are very subtle visually (Guzman-Verri et al., 2001) . This is in contrast to pathogens with Type 3 or 4 secretion systems, in which the pathogen injects effector proteins into the host cell cytoplasm that interfere with GTPases directly, with Rac and Cdc42 being the most common targets (as it the case for S. typhimurium). This process tends to lead to drastic, dramatic, localized actin manipulations and membrane ruffling, termed 'trigger'-type phagocytosis. The involvement of RhoA in GBS invasion of HeLa cells demonstrated in this investigation and its relation to 'zipper-type' phagocytosis correlates with previous findings using transmission electron microscopy to examine GBS invasion of HeLa cells, whereby the host cell membrane appears to wrap tightly around the chains of GBS during the invasion process (Tyrrell et al., 2002) .
In the eukaryotic cell, Rho GTPases link stimuli to cytoskeletal plasticity by directing actin rearrangement in the cell. It is still unclear at this time precisely how GBS triggers activation of Rho GTPases or what binding partners Rho GTPases may interact with in response to GBS invasion; this is a topic of ongoing investigation. Rho GTPases also have the ability to activate and regulate one another; interplay at this level could also be an essential component of the GBS invasion process.
In conclusion, using the HeLa cell culture model, it was found that Rac, Rho, and Cdc42 each participate in GBS invasion into epithelial cells. Rac, Rho, and Cdc42 link extracellular signals to the formation of stress fibers, lamellipodia, or filpodia, respectively (Tapon & Hall, 1997; Hall, 1998; Burridge & Wennerberg, 2004) . The involvement of the Rho-family GTPases in GBS invasion may indicate that these cellular structures participate in GBS invasion of into epithelial cells, or may act synergistically to promote GBS uptake.
